Neelima Radhakrishnan
Overview
Explore the profile of Neelima Radhakrishnan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
100
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bhargavan R, Augustine P, Cherian K, Krishna J, Radhakrishnan N
Indian J Surg Oncol
. 2024 Nov;
15(4):857-863.
PMID: 39555364
The role of sentinel lymph node biopsy (SLNB) in locally advanced breast cancer (LABC) post-neoadjuvant chemotherapy (NACT) is debatable. We conducted a novel pilot study in which pre-NACT tattooing of...
2.
Babu G, Rajeev K, Mathew A, Arjunan A, Priya B, Bhargavan R, et al.
South Asian J Cancer
. 2024 May;
13(1):45-50.
PMID: 38721099
Geethu Babu The coronavirus pandemic has created havoc in every aspect of life including cancer care and was declared a pandemic. This audit was conducted to study the impact of...
3.
Appasani S, Radhakrishnan N, Mathews A
Indian J Pathol Microbiol
. 2024 Feb;
67(2):312-317.
PMID: 38394436
Context: Central nervous system germ cell tumors (CNSGCTs) though rare is the second most common extragonadal site for GCTs. Aims: To determine the clinicopathological features of CNSGCTs diagnosed at our...
4.
Menon D, Nair S, Radhakrishnan N, Saraf U, Nair M
Neurol India
. 2024 Jan;
71(6):1192-1196.
PMID: 38174457
Objectives: Clinical spectrum of mitochondrial myopathy extends beyond chronic progressive external ophthalmoplegia (CPEO). While information on encephalomyopathies is abundant, clinical data on predominant myopathic presentation of mitochondrial disorders are lacking....
5.
Joy A, Kumar A, Radhakrishnan N
J Cancer Res Ther
. 2023 Dec;
PMID: 38102914
Renal cell carcinoma is one of the most lethal tumors of the urologic system and has high metastatic potential. The usual sites of metastasis are lung, bone, liver adrenal, lymph...
6.
Kamala L, Abraham S, Radhakrishnan N, Mony R
Indian J Surg Oncol
. 2023 Mar;
14(1):150-154.
PMID: 36891411
No abstract available.
7.
Menon R, Arjunan A, Mathews A, Valsalamony J, Radhakrishnan N
Indian J Cancer
. 2023 Mar;
PMID: 36861719
Atypical choroid plexus papilloma is classified as WHO (World Health Organization) Grade II subtype of choroid plexus tumor, and it has intermediate pathological features, prognosis, and clinical outcome rates between...
8.
Abdulla K, Augustine P, Radhakrishnan N, Bhargavan R, Krishna K, Cherian K
Indian J Surg Oncol
. 2023 Jan;
13(4):783-788.
PMID: 36687252
Breast cancer is the most common cancer in women globally(1). It is usually a disease of old age. The incidence of breast cancer in females younger than 40 years is...
9.
Radhakrishnan N, Mathews A, Rajeev K, Nair P, Bhargavan R, Viswanathan A
Indian J Pathol Microbiol
. 2022 Oct;
65(4):772-780.
PMID: 36308179
Context: Tumor budding (TB), poorly differentiated clusters (PDCs), and Ki 67 index are proven adverse prognostic factors in breast carcinoma. Though the relation of Ki 67 index with molecular subtypes...
10.
Gopan G, Kamala L, Radhakrishnan N
Indian J Surg Oncol
. 2022 Jan;
12(Suppl 2):378-382.
PMID: 35035177
Renal cell carcinoma is the third most common malignancy to metastasize to the head and neck region. Among them, parotid is a well-reported site, although limited to case reports. Tumours...